SOT102 – Patient Worthy

First Patient has Been Dosed in a Clinical Trial for Gastric and Pancreatic Cancer

Post author:Trudy Horsting
Post published:May 24, 2022
Post category:gastric cancer Pancreatic Cancer Stomach Cancer

SOTIO Biotech has just announced that the first patient has received the first dose of treatment in their Phase 1/2 trial for SOT102. SOT102 is an investigative treatment for pancreatic…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More